15Aug/13

"PharmaPoint: Chronic Heart Failure – US Drug Forecast and Market Analysis to … – SBWire (press release)

“PharmaPoint: Chronic Heart Failure – US Drug Forecast and Market Analysis to
SBWire (press release)
Boston, MA — (SBWIRE) — 08/15/2013 — GlobalData has released its new Country report, “PharmaPoint: Chronic Heart Failure – US Drug Forecast and Market Analysis to 2022″. The chronic heart failure (CHF) market is a mature market that has been slowly